NewsBite

Local mRNA vaccine production is health experts’ No.1 budget priority

Jill Margo
Jill MargoSenior writer

Subscribe to gift this article

Gift 5 articles to anyone you choose each month when you subscribe.

Subscribe now

Already a subscriber?

Funding for immediate, large-scale manufacture of mRNA vaccines such as those made by Pfizer and Moderna should be a priority in the budget, according to experts who have closely followed the course of COVID-19 in Australia.

To achieve optimum pandemic control, they would also welcome policy support to decouple science and public health from politics, implement proportionate risk management and fund quarantine facilities built to a high national standard that can be scaled up and are near medical facilities.

Loading...
Jill Margo is based in the Sydney office. Jill has won multiple prizes, including two Walkley Awards and is an adjunct associate professor at School of Clinical Medicine, Faculty of Medicine and Health, UNSW Sydney, Australia. Connect with Jill on Twitter. Email Jill at jmargo@afr.com

Subscribe to gift this article

Gift 5 articles to anyone you choose each month when you subscribe.

Subscribe now

Already a subscriber?

Read More

Latest In Health & education

Fetching latest articles

Most Viewed In Policy

    Original URL: https://www.afr.com/link/follow-20180101-p57pcw